K. Credille

发表

Identification of LY2510924, a Novel Cyclic Peptide CXCR4 Antagonist That Exhibits Antitumor Activities in Solid Tumor and Breast Cancer Metastatic Models

Kelly M Credille, Donald Paul, Yu-Hua Hui, 2014, Molecular Cancer Therapeutics.

High-content multiplexed tissue imaging and quantification for cancer drug discovery.

M. Uhlik, J. Stewart, J. Wijsman, 2013, Drug discovery today.

Myostatin Neutralization Results in Preservation of Muscle Mass and Strength in Preclinical Models of Tumor-Induced Muscle Wasting

P. Mitchell, B. Eastwood, V. Wroblewski, 2015, Molecular Cancer Therapeutics.

Hematopoietic Proliferative Lesions in the Spleen of rasH2 Transgenic Mice Treated with MNU

P. Mann, K. Credille, D. Goodman, 2010, Toxicologic pathology.

Recent advances in automated imaging have enabled high-content quantification of tumor phenotypes to aid cancer drug discovery

M. Uhlik, J. Stewart, J. Wijsman, 2012 .

Nonclinical Safety Evaluation of a Transforming Growth Factor β Receptor I Kinase Inhibitor in Fischer 344 Rats and Beagle Dogs

K. Credille, Jamie K. Young, W. Ehlhardt, 2014 .

Variability in Platelet-Derived Growth Factor Receptor Alpha Antibody Specificity May Impact Clinical Utility of Immunohistochemistry Assays

T. Holzer, K. Credille, A. Schade, 2016, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

Cancer Therapy: Preclinical LY2875358, a Neutralizing and Internalizing Anti-MET Bivalent Antibody, Inhibits HGF-Dependent and HGF-Independent MET Activation and Tumor Growth

Ying Tang, J. Manro, K. Credille, 2014 .

Merestinib (LY2801653) inhibits neurotrophic receptor kinase (NTRK) and suppresses growth of NTRK fusion bearing tumors

D. Timm, R. Walgren, P. Ebert, 2018, Oncotarget.

A Novel Eg5 Inhibitor (LY2523355) Causes Mitotic Arrest and Apoptosis in Cancer Cells and Shows Potent Antitumor Activity in Xenograft Tumor Models

S. Akinaga, Y. Yamashita, C. Murakata, 2015, Molecular Cancer Therapeutics.

Abstract 2819: Identification and characterization of a novel smoothened antagonist for the treatment of cancer with deregulated hedgehog signaling

P. Hipskind, Hong Gao, K. Credille, 2011 .

Negative pressure pulmonary edema as a post-anesthetic complication associated with upper airway obstruction in a horse.

K. Credille, N. Ducharme, P. Wilkins, 1996, Veterinary surgery : VS.

Preservation of phenotype in an organotypic cell culture model of a recessive keratinization defect of Norfolk terrier dogs

K. Credille, K. Barnhart, R. Dunstan, 2005, Experimental dermatology.

A heritable keratinization defect of the superficial epidermis in norfolk terriers.

K. Credille, K. Barnhart, R. Dunstan, 2004, Journal of comparative pathology.

A Phase 2 study of prexasertib (LY2606368) in platinum resistant or refractory recurrent ovarian cancer.

I. Vergote, Jung-Min Lee, N. Colombo, 2022, Gynecologic oncology.

Linkage of dermatomyositis in the Shetland Sheepdog to chromosome 35.

K. Credille, K. Murphy, L. A. Clark, 2005, Veterinary dermatology.

Autosomal Recessive Congenital Ichthyosis in American Bulldogs Is Associated With NIPAL4 (ICHTHYIN) Deficiency

K. Credille, E. Mauldin, P. Wang, 2015, Veterinary pathology.

Ultrasensitive Cross-species Measurement of Cardiac Troponin-I Using the Erenna Immunoassay System

J. Todd, Q. Lu, K. Credille, 2008, Toxicologic pathology.

Severe polysaccharide storage myopathy in Belgian and Percheron draught horses.

B. Cooper, B. Valentine, J. Cummings, 1997, Equine veterinary journal.

Systemic mastocytosis in an African fat-tail gecko (Hemitheconyx caudicinctus).

T. Holzer, K. Credille, A. R. Irizarry Rovira, 2014, Journal of comparative pathology.

Fabp3 as a biomarker of skeletal muscle toxicity in the rat: comparison with conventional biomarkers.

Albert Eric Schultze, Kelly M Credille, D. Watson, 2008, Toxicological sciences : an official journal of the Society of Toxicology.

Inhibition of Tumor Growth and Metastasis in Non–Small Cell Lung Cancer by LY2801653, an Inhibitor of Several Oncokinases, Including MET

R. Walgren, J. Manro, J. Wijsman, 2013, Clinical Cancer Research.

Cancer Therapy : Preclinical Inhibition of Tumor Growth andMetastasis in Non – Small Cell Lung Cancer by LY 2801653 , an Inhibitor of Several Oncokinases , Including MET

R. Walgren, J. Manro, J. Wijsman, 2013 .

Morphologic, immunohistochemical, and molecular characterization of hepatosplenic T-cell lymphoma in a dog.

K. Credille, K. Barnhart, R. Dunstan, 2004, Veterinary clinical pathology.

Immunohistochemical application of a highly sensitive and specific murine monoclonal antibody recognising the extracellular domain of the human hepatocyte growth factor receptor (MET)

T. Holzer, K. Credille, J. Lu, 2014, Histopathology.

Biomechanical and histological evaluation of a laparoscopic stapled gastropexy technique in dogs.

K. Credille, J. Flanders, R. Hardie, 1996, Veterinary surgery : VS.

Cancer Therapy : Preclinical LY 2875358 , a Neutralizing and Internalizing Anti-MET Bivalent Antibody , Inhibits HGF-Dependent and HGF-Independent MET Activation and Tumor Growth

Ying Tang, J. Manro, K. Credille, 2014 .

A human monoclonal antibody targeting the stem cell factor receptor (c-Kit) blocks tumor cell signaling and inhibits tumor growth

K. Persaud, K. Paz, K. Credille, 2014, Cancer biology & therapy.

Cross-Platform Comparison of Computer-assisted Image Analysis Quantification of In Situ mRNA Hybridization in Investigative Pathology

Timothy R Holzer, Jeffrey C Hanson, Erin M Wray, 2017, Applied immunohistochemistry & molecular morphology : AIMM.

The Rat Mammary Gland: Morphologic Changes as an Indicator of Systemic Hormonal Perturbations Induced by Xenobiotics

P. Snyder, K. Credille, D. Rudmann, 2007, Toxicologic pathology.

Tasisulam Sodium, an Antitumor Agent That Inhibits Mitotic Progression and Induces Vascular Normalization

G. Evans, M. Uhlik, J. Stewart, 2011, Molecular Cancer Therapeutics.

Inhibition of myostatin prevents microgravity-induced loss of skeletal muscle mass and strength

L. Stodieck, T. Bateman, V. Ferguson, 2020, PloS one.

LY2875358, a Neutralizing and Internalizing Anti-MET Bivalent Antibody, Inhibits HGF-Dependent and HGF-Independent MET Activation and Tumor Growth

Ying Tang, J. Manro, K. Credille, 2014, Clinical Cancer Research.

Detection of left ventricular hypertrophy in rats administered a peroxisome proliferator-activated receptor alpha/gamma dual agonist using natriuretic peptides and imaging.

P. Solter, D. Watson, K. Credille, 2010, Toxicological sciences : an official journal of the Society of Toxicology.

Evaluation of systemic immunologic hyperreactivity after intradermal testing in horses with chronic laminitis.

K. Credille, D. Hood, I. P. Wagner, 2003, American journal of veterinary research.

Parasitic Meningoencephalitis in Nurse Sharks (Ginglymostoma cirratum)

K. Credille, R. Reimschuessel, L. Johnson, 1993, Journal of wildlife diseases.

Effects of 0.5% and 2.0% Sodium Lauryl Sulfate in Male CD-1 Mice From a 3-Month Oral Gavage Toxicity Study

G. Boorman, K. Credille, K. G. Hilbish, 2021, Toxicologic pathology.

Identification of LY2510924, a Novel Cyclic Peptide CXCR4 Antagonist That Exhibits Antitumor Activities in Solid Tumor and Breast Cancer Metastatic Models

M. Uhlik, Sheng-Bin Peng, Xiaoyi Zhang, 2014, Molecular Cancer Therapeutics.

Inhibition of Tumor Growth and Metastasis in Non–Small Cell Lung Cancer by LY2801653, an Inhibitor of Several Oncokinases, Including MET

R. Walgren, J. Manro, J. Wijsman, 2013, Clinical Cancer Research.

Ultrasensitive Cross-species Measurement of Cardiac Troponin-I Using the Erenna Immunoassay System

J. Todd, Q. Lu, K. Credille, 2008, Toxicologic pathology.